HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amir Onn Selected Research

Amir Onn Research Topics

Disease

41Neoplasms (Cancer)
01/2022 - 06/2002
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 06/2002
24Lung Neoplasms (Lung Cancer)
08/2021 - 06/2002
7Neoplasm Metastasis (Metastasis)
01/2021 - 06/2002
6Adenocarcinoma of Lung
10/2019 - 06/2002
5Adenocarcinoma
01/2022 - 01/2017
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 06/2002
3Carcinoma (Carcinomatosis)
01/2021 - 10/2004
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2019 - 11/2003
3Melanoma (Melanoma, Malignant)
09/2013 - 02/2004
2Malignant Pleural Effusion
01/2022 - 09/2014
2Pleural Effusion (Pleural Effusions)
01/2022 - 09/2014
2Asthma (Bronchial Asthma)
05/2021 - 11/2002
1Immune System Diseases (Immune Disorders)
01/2022
1Testicular Neoplasms (Testicular Cancer)
01/2022
1Respiratory Hypersensitivity
05/2021
1Pain (Aches)
01/2020
1Disease Progression
12/2019
1Weight Loss (Weight Reduction)
01/2019
1Microsatellite Instability
01/2018
1Lewis Lung Carcinoma
10/2014

Drug/Important Bio-Agent (IBA)

8ErbB Receptors (EGF Receptor)IBA
04/2022 - 01/2004
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 11/2003
6Tyrosine Kinase InhibitorsIBA
04/2022 - 12/2004
6Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2013
6Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2004
5Paclitaxel (Taxol)FDA LinkGeneric
10/2014 - 11/2003
4LigandsIBA
01/2022 - 10/2007
4Pharmaceutical PreparationsIBA
01/2021 - 02/2004
4Biological ProductsIBA
06/2013 - 11/2002
3Phosphotransferases (Kinase)IBA
01/2021 - 02/2007
3MicroRNAs (MicroRNA)IBA
10/2020 - 09/2013
3vandetanib (ZD6474)IBA
09/2014 - 02/2007
3Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
11/2013 - 02/2004
3Gefitinib (Iressa)FDA Link
07/2012 - 06/2005
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2007 - 01/2005
3Interleukin-8 (Interleukin 8)IBA
03/2007 - 11/2003
2B7-H1 AntigenIBA
01/2022 - 01/2018
2Axitinib (AG 013736)IBA
01/2022 - 04/2021
2Peptides (Polypeptides)IBA
01/2022 - 02/2016
2NivolumabIBA
01/2021 - 01/2019
2Tyrosine (L-Tyrosine)FDA Link
01/2021 - 02/2007
2PlatinumIBA
12/2019 - 01/2017
2Etoposide (VP 16)FDA LinkGeneric
12/2019 - 02/2013
2AntibodiesIBA
11/2018 - 10/2009
2Pemetrexed (MTA)FDA Link
01/2017 - 10/2014
2Cisplatin (Platino)FDA LinkGeneric
10/2014 - 02/2013
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2014 - 02/2007
2Transforming Growth Factor alpha (TGF-alpha)IBA
10/2007 - 01/2004
2Epidermal Growth Factor (EGF)IBA
10/2007 - 02/2007
2Angiogenesis InhibitorsIBA
03/2007 - 05/2005
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
03/2007 - 06/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2005 - 01/2003
2Imatinib Mesylate (Gleevec)FDA Link
01/2005 - 02/2004
2Platelet-Derived Growth FactorIBA
01/2005 - 02/2004
1Neoplasm Antigens (Tumor Antigens)IBA
01/2022
1palbociclibIBA
01/2022
1pembrolizumabIBA
01/2022
1alectinibIBA
01/2022
1avelumabIBA
01/2022
1AntigensIBA
01/2022
1durvalumabIBA
01/2022
1ParaffinIBA
08/2021
1Messenger RNA (mRNA)IBA
08/2021
1Granzymes (Granzyme)IBA
08/2021
1Formaldehyde (Formol)FDA Link
08/2021
1Bovine Serum AlbuminIBA
08/2021
1Methacholine Chloride (Methacholine)FDA Link
05/2021
1EverolimusFDA Link
04/2021
1CalciumIBA
01/2021
1InterferonsIBA
01/2021
1Nerve Growth Factors (Neurotrophins)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1CytokinesIBA
01/2021
1Complement System Proteins (Complement)IBA
12/2020
1Cell-Free Nucleic AcidsIBA
12/2020
1Mechanistic Target of Rapamycin Complex 1IBA
01/2020
1Conditioned Culture MediaIBA
01/2020
1cyclopropapyrroloindoleIBA
10/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019
1AlbuminsIBA
01/2019
1osimertinibIBA
11/2018
1Cetuximab (Erbitux)FDA Link
11/2018
1Thyroid Nuclear Factor 1IBA
01/2017
1big gastrinIBA
02/2016
1pro-gastrin-releasing peptide (31-98)IBA
02/2016
1Growth Factor ReceptorsIBA
10/2014

Therapy/Procedure

19Therapeutics
01/2022 - 06/2002
9Drug Therapy (Chemotherapy)
01/2021 - 06/2005
7Immunotherapy
01/2022 - 01/2019
7Radiotherapy
06/2021 - 06/2005
3Molecular Targeted Therapy
10/2005 - 05/2005
2Precision Medicine
01/2021 - 01/2019
2Catheters
09/2014 - 11/2007
1Ambulatory Care (Outpatient Care)
01/2020
1Tattooing
01/2018
1Electronic Nose
10/2017
1Combination Drug Therapy (Combination Chemotherapy)
01/2017